Doctor Care Anywhere Doubles Free Cash Flow During Productive June Half

Doctor Care Anywhere posts strong profit growth and cash gains, with minimal hype.

What the company is saying

Doctor Care Anywhere Group highlights a more than doubling of free cash flow to £1.5 million for the half-year, positioning this as evidence of robust operational performance. The announcement emphasizes a 6.3% revenue increase to £20.4 million, a 27.1% rise in EBITDA to £2.6 million, and a 28.5% jump in net profit to £600,000. Management points to operational momentum, citing 354,900 consultations (up 1.4%) and a growing proportion of repeat patients, now at 74%. The acquisition of DCA Medicspot is framed as accretive, contributing £900,000 in revenue, while the new partnership with Ramsay Health Care UK is presented as a strategic milestone, albeit with no quantified impact. Subscription revenue growth from 7.1% to 10.8% of total revenue is called out as a positive shift in business mix. The tone is confident, with language focused on realised results and measured optimism about new initiatives.

What the data suggests

Financial disclosures show a clear upward trajectory: free cash flow more than doubled to £1.5 million, revenue rose 6.3% to £20.4 million, and EBITDA increased 27.1% to £2.6 million. Net profit reached £600,000, up 28.5%, while cash and cash equivalents climbed 60.3% to £7.7 million. Consultation volumes grew modestly by 1.4%, and repeat patient rates improved from 72.9% to 74%. The DCA Medicspot acquisition added £900,000 in revenue, but the announcement does not break out its impact on profit or margins. Subscription revenue’s share of total revenue increased to 10.8%, indicating a shift toward more recurring income. Net tangible liabilities declined from £6.8 million to £5.7 million, strengthening the balance sheet. The only forward-looking or qualitative claims relate to the Ramsay Health Care UK partnership, for which no financial contribution or operational targets are disclosed.

Analysis

The announcement is grounded in realised, measurable financial and operational results, with nearly all key claims supported by specific numerical disclosures. Profitability metrics (EBITDA, net profit, free cash flow) are provided alongside revenue and operational data, allowing for a clear assessment of value creation. The only forward-looking element is the partnership with Ramsay Health Care UK, but this is described as an executed agreement rather than an aspirational target, and no exaggerated claims about future financial impact are made. There is no evidence of narrative inflation or overstatement; the language is proportionate to the results. Capital outlays (such as the DCA Medicspot acquisition and convertible loan note) are disclosed transparently, with no attempt to overstate their immediate benefit or obscure their impact. The overall tone is positive but justified by the underlying data.

Risk flags

• ●The Ramsay Health Care UK partnership is described in qualitative terms, with no disclosure of expected revenue, patient volumes, or timing, making its financial impact unclear and subject to execution risk.
• ●The DCA Medicspot acquisition’s contribution is limited to a £900,000 revenue figure, with no detail on integration costs, margin impact, or synergies, leaving open questions about its effect on profitability.
• ●Despite strong cash and profit growth, consultation volumes increased only 1.4%, suggesting that headline financial gains may be driven more by cost control or business mix than by underlying demand growth.
• ●The company maintains a £10.6 million convertible loan note with no principal repayment required until December 2027, which could introduce refinancing or dilution risk if future cash flows do not sustain current momentum.

Bottom line

Doctor Care Anywhere’s half-year update demonstrates tangible improvements in profitability, cash flow, and balance sheet strength, with nearly all headline claims supported by disclosed numbers. The operational story is positive but modest, with only a 1.4% increase in consultation volumes and a small rise in repeat patient share. The DCA Medicspot acquisition and Ramsay Health Care UK partnership are presented as growth levers, but the lack of detailed financial disclosure on either limits visibility into their future impact. There is no evidence of narrative inflation or unsupported hype; the company’s claims are grounded in realised results. Investors should view this as a credible performance update, with the most important takeaway being the company’s improved financial resilience and disciplined reporting. Further disclosure on the financial impact of new partnerships and acquisitions would be needed to change the risk/reward profile materially.

Announcement summary

(ASX: DOC) Doctor Care Anywhere Group more than doubled its free cash flow to £1.5 million during the six months to end June. Revenue of £20.4m was up 6.3% on the previous corresponding period, with £900,000 contributed by the May acquisition of weight management business DCA Medicspot. Doctor Care Anywhere consultation volumes for the period totalled 354,900 (up 1.4%). Repeat patients accounted for 74% of consultations (up from 72.9% at the same time last year), and approximately 75% of all appointments are now delivered to returning patients. Revenue in the group’s existing business grew 1.7% in line with consultation growth of 1.4%, while subscription revenue increased from 7.1% of total revenue to 10.8%. EBITDA for the period increased to £2.6m (up 27.1% on the same time last year). Net profit for the period was £600,000 (up 28.5%).

Disagree with this article?